166 related articles for article (PubMed ID: 24713546)
1. The clinical and diagnostic role of microRNAs in ovarian carcinoma.
Davidson B; Tropé CG; Reich R
Gynecol Oncol; 2014 Jun; 133(3):640-6. PubMed ID: 24713546
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in Ovarian Cancer.
Katz B; Tropé CG; Reich R; Davidson B
Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
[TBL] [Abstract][Full Text] [Related]
3. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
4. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.
Leskelä S; Leandro-García LJ; Mendiola M; Barriuso J; Inglada-Pérez L; Muñoz I; Martínez-Delgado B; Redondo A; de Santiago J; Robledo M; Hardisson D; Rodríguez-Antona C
Endocr Relat Cancer; 2011 Feb; 18(1):85-95. PubMed ID: 21051560
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as prognostic markers in ovarian cancer.
Llauradó M; Majem B; Altadill T; Lanau L; Castellví J; Sánchez-Iglesias JL; Cabrera S; De la Torre J; Díaz-Feijoo B; Pérez-Benavente A; Colás E; Olivan M; Doll A; Alameda F; Matias-Guiu X; Moreno-Bueno G; Carey MS; Del Campo JM; Gil-Moreno A; Reventós J; Rigau M
Mol Cell Endocrinol; 2014 Jun; 390(1-2):73-84. PubMed ID: 24747602
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
Logan M; Hawkins SM
Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
[TBL] [Abstract][Full Text] [Related]
7. miRNAs and ovarian cancer: An overview.
Deb B; Uddin A; Chakraborty S
J Cell Physiol; 2018 May; 233(5):3846-3854. PubMed ID: 28703277
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
Rosario R; Blenkiron C; Shelling AN
Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs regulate several functions of normal tissues and malignancies.
Wen KC; Sung PL; Yen MS; Chuang CM; Liou WS; Wang PH
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):465-9. PubMed ID: 24411027
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].
Slabý O; Krekác D; Hrstka R; Svoboda M; Vyzula R
Cas Lek Cesk; 2008; 147(1):25-31. PubMed ID: 18323039
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.
Mezzanzanica D; Bagnoli M; De Cecco L; Valeri B; Canevari S
Int J Biochem Cell Biol; 2010 Aug; 42(8):1262-72. PubMed ID: 20035894
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
Gandellini P; Folini M; Zaffaroni N
Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics and ovarian cancer.
Nephew KP; Balch C; Zhang S; Huang TH
Cancer Treat Res; 2009; 149():131-46. PubMed ID: 19763434
[No Abstract] [Full Text] [Related]
17. Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours.
Kim TH; Kim YK; Kwon Y; Heo JH; Kang H; Kim G; An HJ
Histopathology; 2010 Nov; 57(5):734-43. PubMed ID: 21083603
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
19. [microRNA: new diagnostic and therapeutic tools in liver disease?].
Gougelet A; Colnot S
Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]